Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Quanterix brings in $56.4mm through FOPO

Executive Summary

Quanterix Corp. (digital immunoassay platforms for life sciences research and diagnostics) netted $56.4mm though the public sale of 2.4mm shares at $25.25. The company plans to use the proceeds to expand its US and international life sciences commercial operations; improve its flagship Simoa bead-based protein detection technology and instruments to support the development of additional assays; fund development and potential regulatory approvals or clearances related to instruments, assay kits, and consumables outside of life science research; and pursue complementary acquisitions or business development opportunities.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies